Medical Tourism

Medical Tourism describes the commercial activity of patients traveling internationally to access medical care outside their home jurisdictions. The activity spans multiple categories — specialized care unavailable in home jurisdictions, accelerated treatment timelines, cost-arbitrage care, and broader cross-border patient-flow patterns.

For Israeli hospitals, international patient flows have operated as a structural component of hospital institutional positioning for several decades. Major patient-flow geographies historically have included:

— The broader Middle East (with growth through the Abraham Accords commercial architecture covered at /glossary/gcc-medical-tourism/) — Russia and the CIS (historically substantial, with continued though changed activity through 2022-2026) — Eastern Europe (substantial Jewish-and-non-Jewish patient flow) — The broader international UHNW patient base

Israeli hospitals' medical-tourism positioning rests on several institutional strengths:

— Multiple major hospitals with Newsweek-recognized international rankings (Sheba and adjacent operators) — Substantial English-language and Russian-language clinical capacity — Specialized expertise in oncology, cardiology, neurology, fertility medicine, and adjacent high-acuity specialties — Integrated research-and-clinical activity supporting access to leading-edge clinical protocols — Geographic and operational accessibility from major Middle Eastern, Russian, and European patient-origin geographies

The post-October 7 environment produced selective international patient-flow disruption through 2023-2024. Recovery patterns through 2025-2026 reflect both the broader regional security environment and the institutional commercial positioning of the major Israeli hospitals.

See also: /glossary/gcc-medical-tourism/, /glossary/hospital-innovation-arm/, /health/sheba-arc/